Kolosis BIO is a leading provider of innovative surgical products primarily in the spine and orthopedic market. As a pure-play biologics company, Kolosis exclusively partners with MTF Biologics to offer superior quality allograft technologies that are backed by MTF’s proprietary processing methods. Kolosis is dedicated to driving innovation and expanding its product offerings, pushing the boundaries of science to enhance patient outcomes.
| Website | http://www.kolosis.com |
| Employees | 22 (22 on RocketReach) |
| Founded | 2020 |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Surgical Products, Spine Surgery, Orthopedic Surgery, Orthopedic Biologics, Bone Graft Substitutes, Biologics, Regenerative Medicine, Tissue Regeneration, Surgical Implants, Medical Devices, Musculoskeletal Health, Orthopedic Implants, Spine Implants, Bone Healing, Tissue Engineering, Surgical Solutions, Advanced Surgical Techniques, Innovative Medical Solutions |
| Competitors | Novozymes, Codexis, Inc., Amyris, Renewable Energy Group, Inc., LanzaTech, Geno, Ceres Global Ag Corp., Aemetis, Solazyme , Inc., Algenol +26 more (view full list) |
Looking for a particular Kolosis BIO employee's phone or email?
Collin Begley is the Founder and Chief Executive Officer of Kolosis BIO.
22 people are employed at Kolosis BIO.
Kolosis BIO is based in Salt Lake City, Utah.